Increased Risk of Acute Myocardial Infarction and Elevated Levels of C-Reactive Protein in Carriers of the Thr-87 Variant of the Atp Receptor P2y11
|
|
|
- Lynn Reed
- 6 years ago
- Views:
Transcription
1 Increased Risk of Acute Myocardial Infarction and Elevated Levels of C-Reactive Protein in Carriers of the Thr-87 Variant of the Atp Receptor P2y11 S. Amisten, et al. Eur Heart J (2007) 28;13-8 n&list_uids= Increased Risk of Acute Myocardial Infarction and Elevated Levels of C-Reactive Protein in Carriers of the Thr-87 Variant of the Atp Receptor P2y11 S. Amisten, et al. Eur Heart J (2007) 28;13-8 n&list_uids= Genetic Polymorphisms of Platelet Glycoprotein Ia and the Risk for Premature Myocardial Infarction: Effects on the Release of Scd40l During the Acute Phase of Premature Myocardial Infarction C. Antoniades, et al. J Am Coll Cardiol (2006) 47; n&list_uids= Genetic Polymorphisms of Platelet Glycoprotein Ia and the Risk for Premature Myocardial Infarction: Effects on the Release of Scd40l During the Acute Phase of Premature Myocardial Infarction C. Antoniades, et al. J Am Coll Cardiol (2006) 47; n&list_uids= Effects of Clopidogrel on Soluble Cd40 Ligand and on High-Sensitivity C-Reactive Protein in Patients with Stable Coronary Artery Disease R. R. Azar, et al. Am Heart J (2006) 151;521 e1-521 e4 n&list_uids= Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (Hope) Study S. Blankenberg, et al. Circulation (2006) 114;201-8 n&list_uids= Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction K. H. Bonaa, et al. N Engl J Med (2006) 354; n&list_uids= Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction K. H. Bonaa, et al. N Engl J Med (2006) 354; n&list_uids= High-Dose Atorvastatin Improves Hypercholesterolemic Coronary Endothelial Dysfunction without Improving the Angiogenic Response M. Boodhwani, et al. Circulation (2006) 114;I402-8 n&list_uids=
2 Relation of Various Plasma Growth Factor Levels in Patients with Stable Angina Pectoris and Total Occlusion of a Coronary Artery to the Degree of Coronary Collaterals C. Briguori, et al. Am J Cardiol (2006) 97;472-6 n&list_uids= Enhanced Inflammatory Response to Coronary Stenting Marks the Development of Clinically Relevant Restenosis A. M. Caixeta, et al. Catheter Cardiovasc Interv (2007) 69;500-7 n&list_uids= Dimethyl Sulfoxide Inhibits Tissue Factor Expression, Thrombus Formation, and Vascular Smooth Muscle Cell Activation: A Potential Treatment Strategy for Drug-Eluting Stents G. G. Camici, et al. Circulation (2006) 114; n&list_uids= Usefulness of the White Blood Cell Count as a Predictor of Angiographic Findings in an Unselected Population Referred for Coronary Angiography E. Cavusoglu, et al. Am J Cardiol (2006) 98; n&list_uids= A Modified Balloon Crush Approach Improves Side Branch Access and Side Branch Stent Apposition During Crush Stenting of Coronary Bifurcation Lesions N. Collins and V. Dzavik Catheter Cardiovasc Interv (2006) 68; n&list_uids= Elevated Matrix Metalloproteinase-9 Associated with Stroke or Cardiovascular Death in Patients with Carotid Stenosis N. Eldrup, et al. Circulation (2006) 114; n&list_uids= Interleukin-6 and the Risk of Future Cardiovascular Events in Patients with Angina Pectoris and/or Healed Myocardial Infarction E. Z. Fisman, et al. Am J Cardiol (2006) 98;14-8 n&list_uids= The Significance of Circulating Levels of Both Cardiac Troponin I and High Sensitivity C Reactive Protein for the Prediction of Intravenous Thrombolysis Outcome in Patients with St-Segment Elevation Myocardial Infarction S. G. Foussas, et al. Heart (2007) n&list_uids= The Significance of Circulating Levels of Both Cardiac Troponin I and High Sensitivity C Reactive Protein for the Prediction of Intravenous Thrombolysis Outcome in Patients with St-Segment Elevation Myocardial Infarction S. G. Foussas, et al. Heart (2007) n&list_uids= Long-Term Prognostic Significance of High-Sensitivity C-Reactive Protein before and after Coronary Angioplasty in Patients with Stable Angina Pectoris O. Gach, et al. Am J
3 Cardiol (2007) 99;31-5 n&list_uids= Elevated Creatine Kinase-Mb with Normal Creatine Kinase Predicts Worse Outcomes in Patients with Acute Coronary Syndromes: Results from 4 Large Clinical Trials J. M. Galla, et al. Am Heart J (2006) 151;16-24 n&list_uids= C-Reactive Protein, Clinical Outcome, and Restenosis Rates after Implantation of Different Drug-Eluting Stents A. Gaspardone, et al. Am J Cardiol (2006) 97; n&list_uids= Comparison of Effects of Bare Metal Versus Drug-Eluting Stent Implantation on Biomarker Levels Following Percutaneous Coronary Intervention for Non-St-Elevation Acute Coronary Syndrome C. M. Gibson, et al. Am J Cardiol (2006) 97; n&list_uids= Association between Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade, Biomarkers, and Clinical Outcomes among Patients with Moderate- to High-Risk Acute Coronary Syndromes: Observations from the Randomized Trial to Evaluate the Relative Protection against Post-Pci Microvascular Dysfunction and Post-Pci Ischemia among Antiplatelet and Antithrombotic Agents-Thrombolysis in Myocardial Infarction 30 (Protect-Timi 30) C. M. Gibson, et al. Am Heart J (2006) 152; n&list_uids= Statin Use and Functional Decline in Patients with and without Peripheral Arterial Disease J. Giri, et al. J Am Coll Cardiol (2006) 47; n&list_uids= Preprocedural C-Reactive Protein Levels Predict Myocardial Necrosis after Successful Coronary Stenting in Patients with Stable Angina A. Goldberg, et al. Am Heart J (2006) 151; n&list_uids= The Diagnostic and Prognostic Impact of the Redefinition of Acute Myocardial Infarction: Lessons from the Global Registry of Acute Coronary Events (Grace) S. G. Goodman, et al. Am Heart J (2006) 151; n&list_uids= Association of Paraoxonase-1 Activity and Concentration with Angiographic Severity and Extent of Coronary Artery Disease M. Graner, et al. J Am Coll Cardiol (2006) 47; n&list_uids= Relation between Lipoprotein(a) and Fibrinogen and Serial Intravascular Ultrasound Plaque Progression in Left Main Coronary Arteries M. Hartmann, et al. J Am Coll
4 Cardiol (2006) 48; n&list_uids= Time Course of C-Reactive Protein Reduction with Simvastatin Therapy in Patients with Type 2 Diabetes Mellitus T. L. Hernandez, et al. Am J Cardiol (2006) 98; n&list_uids= Usefulness of Plasma Brain Natriuretic Peptide Concentration for Predicting Subsequent Left Ventricular Remodeling after Coronary Angioplasty in Patients with Acute Myocardial Infarction A. Hirayama, et al. Am J Cardiol (2006) 98;453-7 n&list_uids= Usefulness of Plasma Brain Natriuretic Peptide Concentration for Predicting Subsequent Left Ventricular Remodeling after Coronary Angioplasty in Patients with Acute Myocardial Infarction A. Hirayama, et al. Am J Cardiol (2006) 98;453-7 n&list_uids= Relation of Soft Plaque and Elevated Preprocedural High-Sensitivity C-Reactive Protein Levels to Incidence of in-stent Restenosis after Successful Coronary Artery Stenting Y. J. Hong, et al. Am J Cardiol (2006) 98;341-5 n&list_uids= Usefulness of Combined White Blood Cell Count and Plasma Glucose for Predicting in-hospital Outcomes after Acute Myocardial Infarction M. Ishihara, et al. Am J Cardiol (2006) 97; n&list_uids= Usefulness of Combined White Blood Cell Count and Plasma Glucose for Predicting in-hospital Outcomes after Acute Myocardial Infarction M. Ishihara, et al. Am J Cardiol (2006) 97; n&list_uids= Troponin-T and N-Terminal Pro-B-Type Natriuretic Peptide Predict Mortality Benefit from Coronary Revascularization in Acute Coronary Syndromes: A Gusto-Iv Substudy S. K. James, et al. J Am Coll Cardiol (2006) 48; n&list_uids= Improved Identification of Patients with Coronary Artery Disease by the Use of New Lipid and Lipoprotein Biomarkers N. Johnston, et al. Am J Cardiol (2006) 97;640-5 n&list_uids= Early Invasive Treatment Benefits Patients with Renal Dysfunction in Unstable Coronary Artery Disease N. Johnston, et al. Am Heart J (2006) 152; n&list_uids= Relation of C-Reactive Protein Level and Long-Term Risk of Death or Myocardial
5 Infarction Following Percutaneous Coronary Intervention with a Sirolimus-Eluting Stent J. Karha, et al. Am J Cardiol (2006) 98;616-8 n&list_uids= Relation of C-Reactive Protein Level and Long-Term Risk of Death or Myocardial Infarction Following Percutaneous Coronary Intervention with a Sirolimus-Eluting Stent J. Karha, et al. Am J Cardiol (2006) 98;616-8 n&list_uids= Optimizing Use of Revascularization and Clinical Outcomes in St-Elevation Myocardial Infarction: Insights from the Gusto-V Trial P. Kaul, et al. Eur Heart J (2006) 27; n&list_uids= Optimizing Use of Revascularization and Clinical Outcomes in St-Elevation Myocardial Infarction: Insights from the Gusto-V Trial P. Kaul, et al. Eur Heart J (2006) 27; n&list_uids= The Impact of the Esc/Acc Redefinition of Myocardial Infarction and New Sensitive Troponin Assays on the Frequency of Acute Myocardial Infarction P. A. Kavsak, et al. Am Heart J (2006) 152; n&list_uids= The Impact of the Esc/Acc Redefinition of Myocardial Infarction and New Sensitive Troponin Assays on the Frequency of Acute Myocardial Infarction P. A. Kavsak, et al. Am Heart J (2006) 152; n&list_uids= Limiting Myocardial Damage During Acute Myocardial Infarction by Inhibiting C-Reactive Protein R. N. Kitsis and I. Jialal N Engl J Med (2006) 355;513-5 n&list_uids= Limiting Myocardial Damage During Acute Myocardial Infarction by Inhibiting C-Reactive Protein R. N. Kitsis and I. Jialal N Engl J Med (2006) 355;513-5 n&list_uids= Serum Concentrations of Adiponectin and Risk of Type 2 Diabetes Mellitus and Coronary Heart Disease in Apparently Healthy Middle-Aged Men: Results from the 18-Year Follow-up of a Large Cohort from Southern Germany W. Koenig, et al. J Am Coll Cardiol (2006) 48; n&list_uids= Combined Prognostic Utility of St Segment in Lead Avr and Troponin T on Admission in Non-St-Segment Elevation Acute Coronary Syndromes M. Kosuge, et al. Am J Cardiol (2006) 97;334-9 n&list_uids=
6 Combined Prognostic Utility of St Segment in Lead Avr and Troponin T on Admission in Non-St-Segment Elevation Acute Coronary Syndromes M. Kosuge, et al. Am J Cardiol (2006) 97;334-9 n&list_uids= Prediction of Coronary Heart Disease in a Population with High Prevalence of Diabetes and Albuminuria: The Strong Heart Study E. T. Lee, et al. Circulation (2006) 113; n&list_uids= Intense Vasoconstriction in Response to Aspirate from Stented Saphenous Vein Aortocoronary Bypass Grafts K. Leineweber, et al. J Am Coll Cardiol (2006) 47;981-6 n&list_uids= Plasma Phospholipid Trans Fatty Acids, Fatal Ischemic Heart Disease, and Sudden Cardiac Death in Older Adults: The Cardiovascular Health Study R. N. Lemaitre, et al. Circulation (2006) 114; n&list_uids= Elevated Placental Growth Factor Levels Are Associated with Adverse Outcomes at Four-Year Follow-up in Patients with Acute Coronary Syndromes T. Lenderink, et al. J Am Coll Cardiol (2006) 47; n&list_uids= Matrix Metalloproteinase-7 Affects Connexin-43 Levels, Electrical Conduction, and Survival after Myocardial Infarction M. L. Lindsey, et al. Circulation (2006) 113; n&list_uids= Frequency of Sudden Cardiac Death among Acute Myocardial Infarction Survivors with Optimized Medical and Revascularization Therapy T. H. Makikallio, et al. Am J Cardiol (2006) 97;480-4 n&list_uids= Frequency of Sudden Cardiac Death among Acute Myocardial Infarction Survivors with Optimized Medical and Revascularization Therapy T. H. Makikallio, et al. Am J Cardiol (2006) 97;480-4 n&list_uids= Significance of Total and Differential Leucocyte Count in Patients with Acute Myocardial Infarction Treated with Primary Coronary Angioplasty M. Mariani, et al. Eur Heart J (2006) 27; n&list_uids= Significance of Total and Differential Leucocyte Count in Patients with Acute Myocardial Infarction Treated with Primary Coronary Angioplasty M. Mariani, et al. Eur Heart J (2006) 27;2511-5
7 n&list_uids= Role of Endogenous Fas (Cd95/Apo-1) Ligand in Balloon-Induced Apoptosis, Inflammation, and Neointima Formation C. M. Matter, et al. Circulation (2006) 113; n&list_uids= Riboflavin Lowers Homocysteine in Individuals Homozygous for the Mthfr 677c->T Polymorphism H. McNulty, et al. Circulation (2006) 113;74-80 n&list_uids= Comparison of Aspirin Resistance in Type 1 Versus Type 2 Diabetes Mellitus S. S. Mehta, et al. Am J Cardiol (2006) 97; n&list_uids= Relationship between Homocysteine and Mortality in Chronic Kidney Disease V. Menon, et al. Circulation (2006) 113; n&list_uids= Role of Prophylactic Intra-Aortic Balloon Pump in High-Risk Patients Undergoing Percutaneous Coronary Intervention S. Mishra, et al. Am J Cardiol (2006) 98; n&list_uids= Additive Value of Immunoassay-Measured Fibrinogen and High-Sensitivity C-Reactive Protein Levels for Predicting Incident Cardiovascular Events S. Mora, et al. Circulation (2006) 114;381-7 n&list_uids= Clinical Relevance of C-Reactive Protein During Follow-up of Patients with Acute Coronary Syndromes in the Aggrastat-to-Zocor Trial D. A. Morrow, et al. Circulation (2006) 114;281-8 n&list_uids= The Reduction of Inflammatory Biomarkers by Statin, Fibrate, and Combination Therapy among Diabetic Patients with Mixed Dyslipidemia: The Diacor (Diabetes and Combined Lipid Therapy Regimen) Study J. B. Muhlestein, et al. J Am Coll Cardiol (2006) 48; n&list_uids= Nt-Probrain Natriuretic Peptide Predicts Complexity and Severity of the Coronary Lesions in Patients with Non-St-Elevation Acute Coronary Syndromes J. L. Navarro Estrada, et al. Am Heart J (2006) 151;1093 e1-7 n&list_uids= Frequency and Clinical Implications of Discordant Creatine Kinase-Mb and Troponin Measurements in Acute Coronary Syndromes L. K. Newby, et al. J Am Coll Cardiol
8 (2006) 47;312-8 n&list_uids= Endothelin-1 and Acute Myocardial Infarction: A No-Reflow Mediator after Successful Percutaneous Myocardial Revascularization G. Niccoli, et al. Eur Heart J (2006) 27; n&list_uids= Endothelin-1 and Acute Myocardial Infarction: A No-Reflow Mediator after Successful Percutaneous Myocardial Revascularization G. Niccoli, et al. Eur Heart J (2006) 27; n&list_uids= Prognostic Utility of Heart-Type Fatty Acid Binding Protein in Patients with Acute Coronary Syndromes M. O'Donoghue, et al. Circulation (2006) 114;550-7 n&list_uids= Lipoprotein-Associated Phospholipase A2 and Its Association with Cardiovascular Outcomes in Patients with Acute Coronary Syndromes in the Prove It-Timi 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction) Trial M. O'Donoghue, et al. Circulation (2006) 113; n&list_uids= Prognostic Value of C-Reactive Protein and Cardiac Troponin I in Primary Percutaneous Interventions for St-Elevation Myocardial Infarction P. Ohlmann, et al. Am Heart J (2006) 152; n&list_uids= Prognostic Value of C-Reactive Protein and Cardiac Troponin I in Primary Percutaneous Interventions for St-Elevation Myocardial Infarction P. Ohlmann, et al. Am Heart J (2006) 152; n&list_uids= Plasma Adiponectin Levels Are Associated with Coronary Lesion Complexity in Men with Coronary Artery Disease F. Otsuka, et al. J Am Coll Cardiol (2006) 48; n&list_uids= D-Dimer Testing to Determine the Duration of Anticoagulation Therapy G. Palareti, et al. N Engl J Med (2006) 355; n&list_uids= Prognostic Impact of Preprocedural C-Reactive Protein Levels on Six-Month Angiographic and One-Year Clinical Outcomes after Drug-Eluting Stent Implantation D. W. Park, et al. Heart (2007) n&list_uids=
9 Expression of Heat Shock Protein 27 in Human Atherosclerotic Plaques and Increased Plasma Level of Heat Shock Protein 27 in Patients with Acute Coronary Syndrome H. K. Park, et al. Circulation (2006) 114; n&list_uids= Isolated Elevation in Troponin T after Percutaneous Coronary Intervention Is Associated with Higher Long-Term Mortality A. Prasad, et al. J Am Coll Cardiol (2006) 48; n&list_uids= Impact of Percutaneous Coronary Intervention on the Levels of Interleukin-6 and C-Reactive Protein in the Coronary Circulation of Subjects with Coronary Artery Disease M. M. Ramadan, et al. Am J Cardiol (2006) 98;915-7 n&list_uids= Association of Hemoglobin a(1c) Level with the Severity of Coronary Artery Disease in Patients with Diabetes Mellitus G. Ravipati, et al. Am J Cardiol (2006) 97;968-9 n&list_uids= Comparison of B-Type Natriuretic Peptides for Assessment of Cardiac Function and Prognosis in Stable Ischemic Heart Disease M. Richards, et al. J Am Coll Cardiol (2006) 47;52-60 n&list_uids= Usefulness of Preprocedural Serum N-Terminal Pro-Brain Natriuretic Peptide Levels to Predict Long-Term Outcome after Percutaneous Coronary Intervention in Patients with Normal Troponin T Levels N. Saleh, et al. Am J Cardiol (2006) 97;830-4 n&list_uids= Prognostic Usefulness of White Blood Cell Count on Admission and One-Year Outcome in Patients with Non-St-Segment Elevation Acute Chest Pain J. Sanchis, et al. Am J Cardiol (2006) 98;885-9 n&list_uids= Thromboxane-Dependent Cd40 Ligand Release in Type 2 Diabetes Mellitus F. Santilli, et al. J Am Coll Cardiol (2006) 47;391-7 n&list_uids= Serum Tenascin-C Might Be a Novel Predictor of Left Ventricular Remodeling and Prognosis after Acute Myocardial Infarction A. Sato, et al. J Am Coll Cardiol (2006) 47; n&list_uids= Serum Tenascin-C Might Be a Novel Predictor of Left Ventricular Remodeling and Prognosis after Acute Myocardial Infarction A. Sato, et al. J Am Coll Cardiol (2006) 47;
10 n&list_uids= Adiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis N. Sattar, et al. Circulation (2006) 114;623-9 n&list_uids= B-Type Natriuretic Peptide and the Risk of Cardiovascular Events and Death in Patients with Stable Angina: Results from the Atherogene Study R. Schnabel, et al. J Am Coll Cardiol (2006) 47;552-8 n&list_uids= Interleukin-8 Is Associated with Circulating Cd133+ Progenitor Cells in Acute Myocardial Infarction K. Schomig, et al. Eur Heart J (2006) 27; n&list_uids= Interleukin-8 Is Associated with Circulating Cd133+ Progenitor Cells in Acute Myocardial Infarction K. Schomig, et al. Eur Heart J (2006) 27; n&list_uids= Comparison of Apolipoprotein-B/Apolipoprotein-Ai in Subjects with Versus without the Metabolic Syndrome J. Sierra-Johnson, et al. Am J Cardiol (2006) 98; n&list_uids= Impact of C-Reactive Protein and Fibrinogen on Cardiovascular Prognosis in Patients with Stable Angina Pectoris: The Atherogene Study J. M. Sinning, et al. Eur Heart J (2006) 27; n&list_uids= Ventricular Ectopy: Impact of Self-Reported Stress after Myocardial Infarction P. J. Smith, et al. Am Heart J (2007) 153;133-9 n&list_uids= Ancillary Studies in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (Bari 2d) Trial: Synergies and Opportunities B. E. Sobel Am J Cardiol (2006) 97;53G-58G n&list_uids= Cardiac Troponin T at 96 Hours after Acute Myocardial Infarction Correlates with Infarct Size and Cardiac Function H. Steen, et al. J Am Coll Cardiol (2006) 48; n&list_uids= Relation of Microalbuminuria and Coronary Artery Disease in Patients with and without Diabetes Mellitus R. Sukhija, et al. Am J Cardiol (2006) 98; n&list_uids= Increased Cardiac Adenylyl Cyclase Expression Is Associated with Increased Survival after Myocardial Infarction T. Takahashi, et al. Circulation (2006) 114;388-96
11 n&list_uids= Prognostic Value of Preoperative Cardiac Troponin I in Patients Undergoing Emergency Coronary Artery Bypass Surgery with Non-St-Elevation or St-Elevation Acute Coronary Syndromes M. Thielmann, et al. Circulation (2006) 114;I n&list_uids= Oxidized Phospholipids Predict the Presence and Progression of Carotid and Femoral Atherosclerosis and Symptomatic Cardiovascular Disease: Five-Year Prospective Results from the Bruneck Study S. Tsimikas, et al. J Am Coll Cardiol (2006) 47; n&list_uids= Usefulness of Preprocedural Soluble Cd40 Ligand for Predicting Restenosis after Percutaneous Coronary Intervention in Patients with Stable Coronary Artery Disease S. Turker, et al. Am J Cardiol (2006) 97; n&list_uids= Apolipoprotein E Genotype and Circulating Interleukin-10 Levels in Patients with Stable and Unstable Coronary Artery Disease D. N. Tziakas, et al. J Am Coll Cardiol (2006) 48; n&list_uids= Usefulness of Preoperative C-Reactive Protein and Soluble Intercellular Adhesion Molecule-1 Level for Predicting Future Cardiovascular Events after Coronary Artery Bypass Grafting P. van der Harst, et al. Am J Cardiol (2006) 97; n&list_uids= Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death T. J. Wang, et al. N Engl J Med (2006) 355; n&list_uids= Vkorc1 Haplotypes Are Associated with Arterial Vascular Diseases (Stroke, Coronary Heart Disease, and Aortic Dissection) Y. Wang, et al. Circulation (2006) 113; n&list_uids= A Model for Troponin I as a Quantitative Predictor of in-hospital Mortality D. A. Waxman, et al. J Am Coll Cardiol (2006) 48; n&list_uids= Specific Temporal Profile of Matrix Metalloproteinase Release Occurs in Patients after Myocardial Infarction: Relation to Left Ventricular Remodeling C. S. Webb, et al. Circulation (2006) 114; n&list_uids= Short- and Long-Term Risk Stratification in Acute Coronary Syndromes: The Added Value of Quantitative St-Segment Depression and Multiple Biomarkers C. M.
12 Westerhout, et al. J Am Coll Cardiol (2006) 48; n&list_uids= Integration of B-Type Natriuretic Peptide Levels with Clinical Data and Exercise Testing for Predicting Coronary Artery Disease T. Wolber, et al. Am J Cardiol (2006) 98;764-7 n&list_uids= Impact of Low High-Density Lipoproteins on in-hospital Events and One-Year Clinical Outcomes in Patients with Non-St-Elevation Myocardial Infarction Acute Coronary Syndrome Treated with Drug-Eluting Stent Implantation R. M. Wolfram, et al. Am J Cardiol (2006) 98;711-7 n&list_uids= Prognostic Value of Growth-Differentiation Factor-15 in Patients with Non-St-Elevation Acute Coronary Syndrome K. C. Wollert, et al. Circulation (2007) 115; n&list_uids= Is Plasma Oxidized Low-Density Lipoprotein, Measured with the Widely Used Antibody 4e6, an Independent Predictor of Coronary Heart Disease among U.S. Men and Women? T. Wu, et al. J Am Coll Cardiol (2006) 48;973-9 n&list_uids= Detection of Von Willebrand Factor and Tissue Factor in Platelets-Fibrin Rich Coronary Thrombi in Acute Myocardial Infarction A. Yamashita, et al. Am J Cardiol (2006) 97;26-8 n&list_uids= Detection of Von Willebrand Factor and Tissue Factor in Platelets-Fibrin Rich Coronary Thrombi in Acute Myocardial Infarction A. Yamashita, et al. Am J Cardiol (2006) 97;26-8 n&list_uids= Impact of Clopidogrel on Suppression of Circulating Levels of Soluble Cd40 Ligand in Patients with Unstable Angina Undergoing Coronary Stenting H. K. Yip, et al. Am J Cardiol (2006) 97;192-4 n&list_uids= Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Year-Old Men: A Community-Based Cohort Study B. Zethelius, et al. Circulation (2006) 113; n&list_uids=
Comparison of Sirolimus Versus Paclitaxel Eluting Stents for Treatment of Coronary in-stent Restenosis F. Airoldi, et al. Am J Cardiol (2006)
Comparison of Sirolimus Versus Paclitaxel Eluting Stents for Treatment of Coronary in-stent Restenosis F. Airoldi, et al. Am J Cardiol (2006) 97;1182-7 n&list_uids=16616023 Value of the American College
Gender-Based Outcomes in Percutaneous Coronary Intervention with Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic
Gender-Based Outcomes in Percutaneous Coronary Intervention with Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic Registry) J. D. Abbott, et al. Am J Cardiol (2007) 99;626-31
1. Prevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: data from the Heart and Soul study Hsieh, B.P., et al. Am
FastTest. You ve read the book now test yourself
FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. The answers will refer you back to
The Final 10-Year Follow-up Results from the Bari Randomized Trial J Am Coll Cardiol (2007) 49;1600-6
The Final 10-Year Follow-up Results from the Bari Randomized Trial J Am Coll Cardiol (2007) 49;1600-6 n&list_uids=17433949 64-Multislice Detector Computed Tomography Coronary Angiography as Potential Alternative
Cover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/21543 holds various files of this Leiden University dissertation Author: Dharma, Surya Title: Perspectives in the treatment of cardiovascular disease :
Biomarkers in Acute Cardiac Disease Samir Arnaout, M.D.FESC Associate Professor of Medicine Internal Medicine i & Cardiology American University of Beirut Time course of the appearance of various markers
Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?
Cronicon OPEN ACCESS CARDIOLOGY Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)? Valentin Hristov* Department of Cardiology, Specialized
Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion
Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol
Pathology of percutaneous interventions (PCI) in coronary arteries. Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL
Pathology of percutaneous interventions (PCI) in coronary arteries Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL Percutaneous Coronary Intervention (PCI) Definition: transcatheter opening of
Twelve-Month Outcomes with a Paclitaxel-Eluting Stent Transitioning from Controlled Trials to Clinical Practice (the Wisdom Registry) A.
Twelve-Month Outcomes with a Paclitaxel-Eluting Stent Transitioning from Controlled Trials to Clinical Practice (the Wisdom Registry) A. Abizaid, et al. Am J Cardiol (2006) 98;1028-32 n&list_uids=17027565
Heart disease is the leading cause of death
ACS AND ANTIPLATELET MANAGEMENT: UPDATED GUIDELINES AND CURRENT TRIALS Christopher P. Cannon, MD,* ABSTRACT Acute coronary syndrome (ACS) is an important cause of morbidity and mortality in the US population
Objectives. Acute Coronary Syndromes; The Nuts and Bolts. Overview. Quick quiz.. How dose the plaque start?
Objectives Acute Coronary Syndromes; The Nuts and Bolts Michael P. Gulseth, Pharm. D., BCPS Pharmacotherapy II Spring 2006 Compare and contrast pathophysiology of unstable angina (UA), non-st segment elevation
Adults With Diagnosed Diabetes
Adults With Diagnosed Diabetes 1990 No data available Less than 4% 4%-6% Above 6% Mokdad AH, et al. Diabetes Care. 2000;23(9):1278-1283. Adults With Diagnosed Diabetes 2000 4%-6% Above 6% Mokdad AH, et
Appendix: ACC/AHA and ESC practice guidelines
Appendix: ACC/AHA and ESC practice guidelines Definitions for guideline recommendations and level of evidence Recommendation Class I Class IIa Class IIb Class III Level of evidence Level A Level B Level
Pharmacologic Therapy of Coronary Disease
Pharmacologic Therapy of Coronary Disease M. MOHSEN IBRAHIM, MD Prof. of Cardiology- Cairo University President of the Egyptian Hypertension Society Introduction Coronary artery disease (CAD) is possibly
54B Subject Index - Innovation in Intervention: i2 Summit 2007J jacc March 6, 2007
54B Subject Index - Innovation in Intervention: i2 Summit 2007J jacc March 6, 2007 Subject Index Ablation-catheter Adenosine Adverse Events/cardiovascular care Predictors of Major Vascular Complications
La Trombosi Arteriosa
La Trombosi Arteriosa Prof. Giovanni Davì Medicina Interna Chieti Platelet activation and thrombosis Harrison 19 edizione Platelets are essential for primary hemostasis and repair of the endothelium They
Pathology of Cardiovascular Interventions. Body and Disease 2011
Pathology of Cardiovascular Interventions Body and Disease 2011 Coronary Artery Atherosclerosis Intervention Goals: Acute Coronary Syndromes: Treat plaque rupture and thrombosis Significant Disease: Prevent
ARMYDA-RECAPTURE (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) trial
ARMYDA-RECAPTURE ( for Reduction of MYocardial Damage during Angioplasty) trial Prospective, multicenter, randomized, double blind trial investigating efficacy of atorvastatin reload in patients on chronic
FACTOR Xa AND PAR-1 BLOCKER : ATLAS-2, APPRAISE-2 & TRACER TRIALS
New Horizons In Atherothrombosis Treatment 2012 순환기춘계학술대회 FACTOR Xa AND PAR-1 BLOCKER : ATLAS-2, APPRAISE-2 & TRACER TRIALS Division of Cardiology, Jeonbuk National University Medical School Jei Keon Chae,
Acute Coronary syndrome
Acute Coronary syndrome 7th Annual Pharmacotherapy Conference ACS Pathophysiology rupture or erosion of a vulnerable, lipidladen, atherosclerotic coronary plaque, resulting in exposure of circulating blood
Dyslipidemia Endothelial dysfunction Free radicals Immunologic
ATHEROSCLEROSIS Hossein Mehrani Professor of Clinical Biochemistry Definition Atherosclerosis: Is a chronic inflammatory process characterized by plaque formation within the vessel wall of arteries and
The changes of serum BDNF, blood lipid and PCI in the elderly patients with coronary heart disease complicated with diabetes mellitus
184 Journal of Hainan Medical University 2016; 22(16): 184-188 Journal of Hainan Medical University http://www.hnykdxxb.com/ The changes of serum BDNF, blood lipid and PCI in the elderly patients with
Acute coronary syndromes
Acute coronary syndromes 1 Acute coronary syndromes Acute coronary syndromes results primarily from diminished myocardial blood flow secondary to an occlusive or partially occlusive coronary artery thrombus.
Supplementary Material to Mayer et al. A comparative cohort study on personalised
Suppl. Table : Baseline characteristics of the patients. Characteristic Modified cohort Non-modified cohort P value (n=00) Age years 68. ±. 69.5 ±. 0. Female sex no. (%) 60 (0.0) 88 (.7) 0.0 Body Mass
Index. Note: Page numbers of article titles are in boldface type.
Cardiol Clin 24 (2006) 299 304 Index Note: Page numbers of article titles are in boldface type. A Abciximab in PCI, 180 182 ACE trial, 182 Actinomycin D-eluting stent, 224 ACUITY trial, 190 Acute myocardial
3/23/2017. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate Europace Oct;14(10): Epub 2012 Aug 24.
Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Explain the efficacy and safety of triple therapy, in regards to thromboembolic and bleeding risk Summarize the guideline recommendations
Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017
Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Explain the efficacy and safety of triple therapy, in regards to thromboembolic and bleeding risk Summarize the guideline recommendations
QUT Digital Repository:
QUT Digital Repository: http://eprints.qut.edu.au/ This is the author s version of this journal article. Published as: Doggrell, Sheila (2010) New drugs for the treatment of coronary artery syndromes.
An update on the management of UA / NSTEMI. Michael H. Crawford, MD
An update on the management of UA / NSTEMI Michael H. Crawford, MD New ACC/AHA Guidelines 2007 What s s new in the last 5 years CT imaging advances Ascendancy of troponin and BNP Clarification of ACEI/ARB
Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Phy
Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Physician, Professor of Medicine Department of Cardiology,
Cardiovascular Disorders Lecture 3 Coronar Artery Diseases
Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in
Belinda Green, Cardiologist, SDHB, 2016
Acute Coronary syndromes All STEMI ALL Non STEMI Unstable angina Belinda Green, Cardiologist, SDHB, 2016 Thrombus in proximal LAD Underlying pathophysiology Be very afraid for your patient Wellens
The MAIN-COMPARE Study
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
Rikshospitalet, University of Oslo
Rikshospitalet, University of Oslo Preventing heart failure by preventing coronary artery disease progression European Society of Cardiology Dyslipidemia 29.08.2010 Objectives The trends in cardiovascular
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice Review consultation document Review of Clinical Guideline (CG95) Chest pain of recent onset: Assessment and diagnosis
Supplementary Table S1: Proportion of missing values presents in the original dataset
Supplementary Table S1: Proportion of missing values presents in the original dataset Variable Included (%) Missing (%) Age 89067 (100.0) 0 (0.0) Gender 89067 (100.0) 0 (0.0) Smoking status 80706 (90.6)
Quinn Capers, IV, MD
Heart Attacks Mended Hearts Presentation, January, 2017 Quinn Capers, IV, MD Associate Professor of Medicine (Cardiovascular Medicine) Director, Transradial Coronary Interventions Division of Cardiovascular
Drug Eluting Stents Sometimes Fail ESC Stockholm 29 Set 2010 Stent Thrombosis Alaide Chieffo
Drug Eluting Stents Sometimes Fail ESC Stockholm 29 Set 2010 Stent Thrombosis 11.45-12.07 Alaide Chieffo San Raffaele Scientific Institute, Milan, Italy Historical Perspective 25 20 15 10 5 0 Serruys 1991
Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI
Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI Gamal Abdelhady, Emad Mahmoud Department of interventional
Abstract. Roman S Tarasov and Vladimir I Ganyukov. Research Institute for Complex Issues of Cardiovascular Diseases, Russia
Chapter 2 Prognostic Role of Initial and Residual Syntax Score in Patients with ST-Segment Elevation Myocardial Infarction after Primary Percutaneous Coronary Intervention Roman S Tarasov and Vladimir
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators
Supplementary Online Content
Supplementary Online Content Valle JA, Tamez H, Abbott JD, et al. Contemporary use and trends in unprotected left main coronary artery percutaneous coronary intervention in the United States: an analysis
CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA
RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA Dr Lincoff is an interventional cardiologist and the Vice Chairman for Research
Role of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University
Role of Clopidogrel in Acute Coronary Syndromes Hossam Kandil,, MD Professor of Cardiology Cairo University ACS Treatment Strategies Reperfusion/Revascularization Therapy Thrombolysis PCI (with/ without
CORONARY CHRONIC TOTAL OCCLUSIONS IN THE SETTING OF ACUTE MYOCARDIAL INFARCTION
CORONARY CHRONIC TOTAL OCCLUSIONS IN THE SETTING OF ACUTE MYOCARDIAL INFARCTION *Bimmer Claessen, Loes Hoebers, José Henriques Department of Cardiology, Academic Medical Center, University of Amsterdam,
LM stenting - Cypher
LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with
THE CURRENT SITUATION AND FUTURE OF THE PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROM IN RUSSIAN FEDERATION
: 616.127-005.8 -..,.. -...,, ( ), 2011, 581 182. 195 592 ( ) 385 590 -. 4,3 % 8,8 % ( ). 2011 62 329,, 24 931 (40 %) -. : - - ; ; 70 % ST ( ST); ST - 24. : ST,. THE CURRENT SITUATION AND FUTURE OF THE
Introduction. Risk factors of PVD 5/8/2017
PATHOPHYSIOLOGY AND CLINICAL FEATURES OF PERIPHERAL VASCULAR DISEASE Dr. Muhamad Zabidi Ahmad Radiologist and Section Chief, Radiology, Oncology and Nuclear Medicine Section, Advanced Medical and Dental
A Randomized Comparison of Clopidogrel and Aspirin Versus Ticlopidine and Aspirin After the Placement of Coronary Artery Stents
Journal of the American College of Cardiology Vol. 41, No. 6, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Science Inc. doi:10.1016/s0735-1097(02)02974-1
Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines)
Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines) Authors: Dr. M. Love, Dr. I. Bata, K. Harrigan
Ischemic heart disease
Ischemic heart disease Introduction In > 90% of cases: the cause is: reduced coronary blood flow secondary to: obstructive atherosclerotic vascular disease so most of the time it is called: coronary artery
To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.
ACETYL SALICYLIC ACID TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.
Controversies in Cardiac Pharmacology
Controversies in Cardiac Pharmacology Thomas D. Conley, MD FACC FSCAI Disclosures I have no relevant relationships with commercial interests to disclose. 1 Doc, do I really need to take all these medicines?
MEDICAL POLICY SUBJECT: INFLAMMATORY MARKERS OF CORONARY ARTERY DISEASE RISK. POLICY NUMBER: CATEGORY: Laboratory Tests
MEDICAL POLICY PAGE: 1 OF: 7 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
Diagnosis and Management of Acute Myocardial Infarction
Diagnosis and Management of Acute Myocardial Infarction Acute Myocardial Infarction (AMI) occurs as a result of prolonged myocardial ischemia Atherosclerosis leads to endothelial rupture or erosion that
Journal of the American College of Cardiology Vol. 47, No. 7, by the American College of Cardiology Foundation ISSN /06/$32.
Journal of the American College of Cardiology Vol. 47, No. 7, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.05.102
Measuring Natriuretic Peptides in Acute Coronary Syndromes
Measuring Natriuretic Peptides in Acute Coronary Syndromes Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP Consultant Cardiologist Chief Academic and Scientific Officer St. John Providence Health
Predictors of 6-Month Angiographic Restenosis inside Bare-Metal Stent in Chinese Patients with Coronary Artery Disease
Original Article Acta Cardiol Sin 2009;25:1 6 Coronary Artery Disease Predictors of 6-Month Angiographic Restenosis inside Bare-Metal Stent in Chinese Patients with Coronary Artery Disease Yung-Lung Chen,
Coronary Plaque Sealing: The DEFER Study and more...
Coronary Plaque Sealing: The DEFER Study and more... How Waiting Can Be Beneficial in Stable Coronary Artery Disease Patients ESC, Stockholm, 2005 M. Romanens, 21.09.2005 at www.kardiolab.ch DEFER Study:
Clinical Investigations
Clinical Investigations Risk Factors of Cardiac Troponin T Elevation in Patients with Stable Coronary Artery Disease After Elective Coronary Drug-Eluting Stent Implantation Zhang-Wei Chen, MD; Ju-Ying
Coronary plaque erosion: a clinical case. Dr. Giampaolo Niccoli, MD, PhD, FESC Institute of Cardiology Catholic University, Rome, Italy
Coronary plaque erosion: a clinical case, MD, PhD, FESC Institute of Cardiology Catholic University, Rome, Italy Coronary plaque erosion: a clinical case B.M. Age: 59 years Sex: female. Cardiological risk
Conference Paper Antithrombotic Therapy in Patients with Acute Coronary Syndromes: Biological Markers and Personalized Medicine
Conference Papers in Medicine, Article ID 719, pages http://dx.doi.org/1.1155/13/719 Conference Paper Antithrombotic Therapy in Patients with Acute Coronary Syndromes: Biological Markers and Personalized
Medicine Dr. Omed Lecture 2 Stable and Unstable Angina
Medicine Dr. Omed Lecture 2 Stable and Unstable Angina Risk stratification in stable angina. High Risk; *post infarct angina, *poor effort tolerance, *ischemia at low workload, *left main or three vessel
Continuing Medical Education Post-Test
Continuing Medical Education Post-Test Based on the information presented in this monograph, please choose one correct response for each of the following questions or statements. Record your answers on
Coronary Artery Disease: Revascularization (Teacher s Guide)
Stephanie Chan, M.D. Updated 3/15/13 2008-2013, SCVMC (40 minutes) I. Objectives Coronary Artery Disease: Revascularization (Teacher s Guide) To review the evidence on whether percutaneous coronary intervention
Impact of Chronic Kidney Disease on Long-Term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary Intervention
Original Article Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal Impact of Chronic Kidney Disease on Long-Term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary
Topic. Updates on Definition of Myocardial Infarction
Topic Updates on Definition of Myocardial Infarction In the past, general consensus for MI? Definition of MI by WHO - Combination of 2 of 3 characteristics - 1. Typical Symptoms 2. Enzyme Rise 3. Typical
Novel Risk Markers in ACS (Hyperglycemia, Anemia, GFR)
Novel Risk Markers in ACS (Hyperglycemia, Anemia, GFR) Shaul Atar, MD Department of Cardiology Faculty of Medicine of the Galilee Western Galilee Medical Center, Nahariya, Israel TIMI Risk Score Age 65
Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.
Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical
Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine
Acute Coronary Syndrome Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Topics Timing is everything So many drugs to choose from What s a MINOCA? 2 Acute
APPENDIX F: CASE REPORT FORM
APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more
Case Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer
Case Presentation Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer Case Presentation 50 YO man NSTEMI treated with PCI 1 month ago Medical History: Obesity: BMI 32,
Journal of the American College of Cardiology Vol. 46, No. 8, by the American College of Cardiology Foundation ISSN /05/$30.
Journal of the American College of Cardiology Vol. 46, No. 8, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.06.070
International Journal of Cardiology and Cardiovascular Research Vol. 1(1), pp , June,
International Journal of Cardiology and Cardiovascular Research Vol. 1(1), pp. 002-006, June, 2014. www.premierpublishers.org. ISSN: XXXX-XXXX IJCCR Research Article Prognostic value of ST segment depression
In-Ho Chae. Seoul National University College of Medicine
The Earlier, The Better: Quantum Progress in ACS In-Ho Chae Seoul National University College of Medicine Quantum Leap in Statin Landmark Trials in ACS patients Randomized Controlled Studies of Lipid-Lowering
ATEF ELBAHRY,FACA,FICA,MISCP,FVBWG.
Hyperglycemia and Coronary Events: where is the link? ATEF ELBAHRY,FACA,FICA,MISCP,FVBWG. Cardiovascular (CV) disease is the primary complication of diabetes ~65% of deaths are due to CV disease Coronary
OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME. TARGET AUDIENCE: All Canadian health care professionals.
OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To review the use of antiplatelet agents and oral
Downloaded from ismj.bpums.ac.ir at 22: on Thursday March 7th 2019
- ( ) - ST. :. (No-reflow). ST :.. SPSS. ( / ) :.(P
Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective
Clinical Seminar Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical
Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines
Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Enrico Ferrari, MD Cardiac Surgery Unit Cardiocentro Ticino Foundation Lugano, Switzerland Conflict of Interests No conflict
Acute and Subacute Stent Thrombosis in a Patient With Clopidogrel Resistance: A Case Report
CSE REPORT DOI 10.4070 / kcj.2009.39.10.434 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright c 2009 The Korean Society of Cardiology Open ccess cute and Subacute Stent Thrombosis in a Patient With
Abstract Background: Methods: Results: Conclusions:
Two-Year Clinical and Angiographic Outcomes of Overlapping Sirolimusversus Paclitaxel- Eluting Stents in the Treatment of Diffuse Long Coronary Lesions Kang-Yin Chen 1,2, Seung-Woon Rha 1, Yong-Jian Li
Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents
Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents Prof. Dr. med. Julinda Mehilli Medizinische Klinik und Poliklinik I Klinikum der Universität München Campus Großhadern Key Factors
What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor
76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class
Unprotected LM intervention
Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline
Timing of Surgery After Percutaneous Coronary Intervention
Timing of Surgery After Percutaneous Coronary Intervention Deepak Talreja, MD, FACC Bayview/EVMS/Sentara Outline/Highlights Timing of elective surgery What to do with medications Stopping anti-platelet
Invited Experts' Case Presentation and 5-Slides Focus Review
Invited Experts' Case Presentation and 5-Slides Focus Review FFR and IVUS in Myocardial Bridging Haegeun, Song. M.D. Heart Institute, Asan Medical Center, Seoul, Korea Myocardial Bridging Common congenital
Correlates of Adverse Events During Saphenous Vein Graft Intervention With Distal Embolic Protection
JACC: CARDIOVASCULAR INTERVENTIONS VOL. 1, NO. 2, 2008 2008 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/08/$34.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2008.01.002 Correlates
Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI
Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist physician Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Outcome objectives of the discussion: At the end of the
PCI for Left Anterior Descending Artery Ostial Stenosis
PCI for Left Anterior Descending Artery Ostial Stenosis Why do you hesitate PCI for LAD ostial stenosis? LAD Ostial Lesion Limitations of PCI High elastic recoil Involvement of the distal left main coronary
Recurrent Thrombosis in a Case of Coronary Ectasia with Large Thrombus Burden Successfully Treated by Adjunctive Warfarin Therapy
Case Report Acta Cardiol Sin 2013;29:462 466 Recurrent Thrombosis in a Case of Coronary Ectasia with Large Thrombus Burden Successfully Treated by Adjunctive Warfarin Therapy Hung-Hao Lee, 1 Tsung-Hsien
Journal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.
Journal of the American College of Cardiology Vol. 48, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.03.039
Coronary Artery Disease in the 21 st Century: An Integrated Approach Based on Science and Art
Coronary Artery Disease in the 21 st Century: An Integrated Approach Based on Science and Art Harisios Boudoulas, MD, Dr, Dr. Hon. Professor, Honorary Professor, Academician Development of Coronary Artery
Summary of Research and Writing Activities In Cardiovascular Disease
Summary of Research and Writing Activities In Cardiovascular Disease Carole Alison Chrvala, PhD 919.545.2149 (Work) 919.951.5230 (Mobile) cchrvala@centurylink.net www.healthmattersmedwriting.com 1 Manuscripts
UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18
UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18 INTRODUCTION The clinical entities that comprise acute coronary syndromes (ACS)-ST-segment
TCT mdbuyline.com Clinical Trial Results Summary
TCT 2012 Clinical Trial Results Summary FAME2 Trial: FFR (fractional flow reserve) guided PCI in all target lesions Patients with significant ischemia, randomized 1:1 Control arm: not hemodynamically significant
Update on Antithrombotic Therapy in Acute Coronary Syndrome
Update on Antithrombotic Therapy in Acute Coronary Syndrome Laura Tsang November 13, 2006 Objectives: By the end of this session, you should understand: The role of antithrombotics in ACS Their mechanisms
Prognostic Significance of High Sensitivity C-Reactive Protein before and after Percutaneous Coronary Intervention in Patients with Angina Pectoris
Med. J. Cairo Univ., Vol. 80, No. 2, June: 267-272, 2012 www.medicaljournalofcairouniversity.com Prognostic Significance of High Sensitivity C-Reactive Protein before and after Percutaneous Coronary Intervention